“The WVC in DC was an incredibly well organized congress. The agenda was packed and sessions were very informative and well thought out. The enthusiasm for the field of vaccines was incredible. 
This meeting enables us to connect to many potential partners and agencies. 
Thank you!”

Dr G Alexander Koglin, PhD, NTxBio


"For many years, I have been disappointed that there really was no premier vaccine meeting analogous to ID Week or ASCO. Vaccine presentations seem to be relegate to either marginal roles at scientific meetings such as ID Week, or to be programmatic in nature (e.g. the NFID program). Under your leadership, in the past few years, the WVC has been transformed from one that is overwhelmingly commercial into one that attracts many of the leaders in the field. It still has a commercial feel, but I think this is counterbalanced by some very strong presentations on a range of topics that are of keen interest to the vaccine community. On the Safety side, I’ve been delighted that we’ve been able to have very active participation in a dedicated safety track over the past two years – one that I’ve been privileged to help coordinate.”

Walter Straus, MD, MPH | Associate Vice-President | Therapeutic Area Head for Vaccines and Infectious Diseases | Clinical Safety & Risk Management | Merck Research Laboratories


“Very enjoyable and productive meeting" 

Jon Heinrichs, Sanofi 


“The Congress this year exceeded my expectations with the comprehensive and timely integration of One Health issues such as emerging zoonotic diseases and AMR that poses a threat to the health and livelihood of people worldwide.”

Cyril Gay, USDA


“The congress itself has improved vastly from the last version I attended in 2011 which was nowhere near as good or as large.”

Professor Jonathan Van-Tam, Deputy Chief Medical Officer, Department of Health, England


“Thank you very much, also for us it was the best WWC!! It was very busy!”

Reinhard Braun, Pantec


“thanks a lot for your outstanding organization, it’s always a pleasure”

Emanuele Montomoli, Cheif Scientific Officer, Full Prof. Public Health, University of Siena


“I have been attending the last three WVC (US and Europe) and this one is by far the best one by the quality of the sciences the organisation.”

Luc Ganon, Neomed Labs 


“Congratulations on such a successful meeting”

Mark Feinberg,CEO, IAVI 


“Many thanks for all your support top the WVC. It was extremely well organized and I have heard nothing but complements about your role and that of colleagues at Terrapin.”

Dr. Robin Nandy, Principal Advisor & Chief of Immunizations, UNICEF


“It was an excellent congress indeed & it was a pleasure to be an active part of the agenda.”

Danilo Casimiro, SVP, R&D, Sanofi 


“This was the best WVC I have attended and I think I have gone to most of them.  It is a great opportunity to meet with high level scientists and business development people who are interested in vaccines.  For me, it is better than BIO, as at WVC, virtually everyone you meet has an interest in some aspect of vaccines.  Incredible networking opportunities.  I feel like I didn’t stop talking for 3 days.”

Andrew Lees, Ph.D Scientific Director, Fina BioSolutions 


“thank you for the outstanding organization of the conference and the wide ranging topics that were presented”

Malte Meppen, GSK


"I enjoyed attending the Congress and you deserve a lot of the credit for making it so good.”

 Walt Orenstein, Emory University